Current Seminars

02/12/2014 - 18:30 - Biopartnering Seminar - Developments and Advancements in Speech Recognition Technology

Speech recognition is defined as a type of pattern recognition that translates a speech signal input into relevant mediums, such as transcribed text. This technology is composed of four blocks, each of which are independently configured and trained: the acoustic model, the language model, the decoder, and the pronunciation dictionary. Although...

25/11/2014 - 18:30 - Biopartnering Seminar - How Can We Improve CPAP Machines For Compliance?

  Obstructive sleep apnea is a form of sleep disordered breathing that occurs when the pharynx repeatedly collapses during sleep. Currently, it is estimated that 858,900 Canadians are affected by sleep apnea, putting them at an increased risk for developing neurocognitive dysfunction, cardiovascular disease, and metabolic disturbances....

11/11/2014 - 18:30 - Biopartnering Seminar Series - `Anatomical Intelligence' Tools in Radiology: How Can We Improve Adoption?

Due to an aging population, there has been an increasing volume of referrals for ultrasound imaging procedures. With a compounded annual growth rate of 6.2%, the ultrasound device market itself is expected to reach $8.1 billion by 2017. Historically, the evolution of ultrasound has relied heavily on advances in computing power; however,...

04/11/2014 - 18:30 - Biopartnering Seminar - Hexoskin Wearable Fitness Technology: Minimal Design Modifications For Market Success

As of October 2014, 21% of consumers in the US own a wearable digital device. With over $2.3 billion currently invested into digital health startups, and an expected 130 million fitness trackers and smart watches on the market by 2018, this trend shows no sign of slowing. One player in this arena is Hexoskin, a wireless biometric shirt developed...

28/10/2014 - 18:30 - Biopartnering Seminar - Xalkori: Increasing Sales of the Biomarker-Based Therapeutic

Lung cancer is currently the most common cause of cancer-related deaths worldwide. In Canada, it is estimated that there will be an incidence of 26,100 new lung cancer cases, with an average 5-year survival rate of  17%. Within the broad scope of lung cancer, the subpopulation of non-small cell lung cancer (NSCLC) accounts for 85% of these...

Pages